Healthcare
Calotren Releases Official Ingredient Fact Sheet, Reaffirming 25-Year Commitment to Stimulant-Free Collagen Supplement
Top of the World Distributors has published an official Ingredient & Safety Fact Sheet for Calotren, emphasizing the supplement's 25-year history as a stimulant-free collagen product to address growing consumer demand for transparency in the health and nutrition industry.
Medical Marijuana Uncertainty Persists Despite Patient Success Stories
Despite compelling patient testimonials about cannabis providing relief where traditional medications failed, medical professionals and lawmakers remain divided on medical marijuana's role in healthcare, creating ongoing uncertainty in the rapidly evolving cannabis industry.
Soligenix Advances Psoriasis Treatment SGX302 with Promising Early Clinical Results
Soligenix is progressing its phase 2a clinical trial of SGX302 for psoriasis treatment, showing encouraging safety and biological activity data that positions the therapy to address a $67 billion global market opportunity.
Annovis Bio Completes Site Activation and Marks First Patient Completions in Pivotal Alzheimer's Phase 3 Trial
Annovis Bio has fully activated all 84 U.S. sites for its pivotal Phase 3 Alzheimer's trial and achieved first patient completions, positioning the company to deliver symptomatic data by late 2026 for its potential neurodegenerative disease therapy buntanetap.
Georgia Law Firm Strengthens Medical Malpractice Advocacy Amid Complex Litigation Landscape
The Moses Firm reinforces its commitment to handling serious medical negligence cases, highlighting the complexity of malpractice litigation and the need for specialized legal and medical expertise to secure justice for victims.
Strawberry Fields REIT CEO Outlines Decade-Long Growth Strategy Amid Aging Population Trends
Strawberry Fields REIT's disciplined financial approach and focus on healthcare property acquisitions position the company to capitalize on America's aging demographic trends while maintaining consistent growth and perfect rent collection.
Datavault AI Grants Scilex Exclusive License for Biotech Exchange Platform in $2.55 Billion Deal
Datavault AI has licensed its AI-driven technology to Scilex for a biotech exchange platform that could address a $2 trillion pharmaceutical market, representing a major advancement in tokenizing and monetizing healthcare assets.
HeartBeam Submits Breakthrough ECG Technology for FDA Clearance
HeartBeam Inc. has submitted its innovative 12-lead ECG synthesis software to the FDA for clearance, representing a significant advancement in cardiac arrhythmia detection and management.
Jupiter Neurosciences Expands Brain Health Reach with Nugevia Supplement Line
Jupiter Neurosciences leverages its pharmaceutical expertise to launch Nugevia MND, a cognitive health supplement that addresses growing global demand for brain health solutions amid aging populations and represents a strategic bridge between clinical research and consumer wellness.
Sigyn Therapeutics Advances CardioDialysis™ to Address Cardiovascular Disease in Dialysis Patients
Sigyn Therapeutics is developing CardioDialysis™, a medical device that leverages existing dialysis infrastructure to treat cardiovascular disease in end-stage renal disease patients, who face a 67% mortality rate from heart conditions and limited benefit from traditional drug therapies.
Lantern Pharma to Host Q3 2025 Results Webcast, Highlighting AI-Driven Oncology Pipeline
Lantern Pharma will review its third-quarter 2025 financial results and AI platform developments during a November webcast, showcasing how artificial intelligence is accelerating cancer drug discovery and development.
Cybin Inc. Announces Q2 2025 Financial Results and Business Update Conference Call
Cybin Inc. will host a conference call on November 13, 2025, to discuss its second-quarter financial results and provide updates on its late-stage neuropsychiatry pipeline, including breakthrough-designated psychedelic treatments for major depressive disorder and generalized anxiety disorder.
Study Reveals Neurocognitive Decline in CNS Cancer Patients, Highlighting Treatment Challenges
Recent research demonstrates significant neurocognitive decline in central nervous system cancer patients, emphasizing the critical need for therapies that address both tumor control and cognitive preservation.
Medical Professional Launches Anti-Aging Skincare System Based on 34 Years of Clinical Experience
Dr. Barbara Sharief introduces an 8-product medical-grade skincare collection developed from her clinical expertise and personal commitment to aging without fillers or injectables, offering a holistic approach to skin health.
Cedars-Sinai Park Launches Immersive Digital Platform to Transform Senior Care Discovery
Portland's historic Cedars-Sinai Park senior campus has unveiled a storytelling-driven digital experience that reimagines how families explore senior care options through emotional connection rather than clinical information.
Shifa Therapy Partners with Mosques and Community Centers to Expand Mental Health Access
Shifa Therapy's partnership with mosques and community centers aims to make culturally sensitive mental health support more accessible to Muslim communities by integrating therapy services into familiar faith-based settings.
MIT and Harvard Researchers Develop Enhanced Natural Killer Cell Therapy for Cancer Treatment
Researchers from MIT and Harvard Medical School have engineered modified natural killer cells that show promising results in fighting cancer while avoiding immune system rejection, potentially transforming cancer immunotherapy approaches.
HeartBeam Receives Buy Rating and $4 Price Target from Roth Capital, Highlighting FDA Clearance Catalyst
HeartBeam Inc. received a Buy rating and $4 price target from Roth Capital, which emphasized the company's potential FDA clearance for its 12-lead ECG synthesis software and its position to transform remote cardiac monitoring.
Cybin Inc. to Present at Guggenheim Healthcare Innovation Conference Amid Phase 3 Mental Health Drug Development
Cybin Inc. announced its participation in the Guggenheim Healthcare Innovation Conference as the company advances its Phase 3 clinical trials for novel mental health treatments, highlighting growing investor interest in innovative neuropsychiatry solutions.
NanoViricides Sets 2025 Annual Shareholders Meeting Amid Clinical Development Push
NanoViricides announced its 2025 shareholders meeting while advancing multiple antiviral drug candidates including NV-387 for respiratory infections and NV-HHV-1 for shingles treatment.
BioUtah Announces 2025 Life Sciences Award Winners Recognizing Utah's Healthcare Innovation Leaders
BioUtah will honor five distinguished individuals and companies at the 2025 Mayer Brown Utah Life Sciences Summit for their transformative contributions to healthcare innovation and economic growth in Utah's life sciences sector.
Las Vegas Emerges as Premier Destination for Luxury Medical Tourism
Signature Plastic Surgery is positioning Las Vegas as a leading destination for high-quality cosmetic surgery, offering patients an alternative to costly metropolitan areas and overseas medical tourism through integrated luxury hospitality experiences.
Austin Chiropractor Prescribes 'Time Out Rx' as Antidote to Modern Burnout Culture
An Austin chiropractor's prescription for strategic pauses addresses the growing epidemic of burnout by focusing on nervous system restoration rather than productivity hacks.
American Heart Association Leverages HBCU Football Game to Promote Cardiac Emergency Preparedness
The American Heart Association used the Battle of the Legends HBCU football game to educate fans about hypertrophic cardiomyopathy and Hands-Only CPR, addressing critical gaps in heart health awareness and emergency response capabilities in underrepresented communities.
Ocumetics Reports Promising Early Results in First Human Lens Implant Study
Ocumetics Technology Corp. announced encouraging one-month vision results from its first human clinical study of an accommodating intraocular lens, showing potential to transform cataract treatment and reduce dependence on corrective lenses.
NeuroOne Granted 180-Day Extension to Regain Nasdaq Compliance
NeuroOne Medical Technologies has received an additional 180 days to meet Nasdaq's minimum bid price requirement, providing crucial breathing room for the neurological device company to stabilize its stock performance and avoid potential delisting.
A Place At Home – North Austin Wins Second Consecutive Best of Round Rock Award
A Place At Home – North Austin has secured the Best of Round Rock Award for the second year, highlighting its community-focused approach to senior care and veteran support through specialized programs and partnerships.
Omaha Chiropractic Clinic Emphasizes Personalized Care and Holistic Wellness Approach
Platinum Chiropractic + Wellness establishes itself as Omaha's premier chiropractic clinic, offering personalized treatment plans and comprehensive wellness services that address root causes of health issues rather than just symptoms.
University of Florida Student Claudia Masmitja Corujo Awarded 2025 Marcus W. Viles Community Growth Scholarship
Claudia Masmitja Corujo, a first-generation college student at the University of Florida, received the $2,500 scholarship for her commitment to community support and healthcare equity, continuing Marcus Viles's legacy of community betterment.
SunKnowledge Expands Virtual Medical Assistant Services Nationwide with Cost-Saving Solutions
SunKnowledge Inc. is transforming healthcare operations across all 50 states by providing specialized virtual medical assistant services that reduce administrative costs by up to 80% while improving efficiency and patient care.